SR-9009 (Stenobolic) - Driada Medical EU

The provided product is SR-9009, commonly known by the research name Stenabolic.¹ It is classified as a metabolic modulator and a REV-ERB agonist.² It is an investigational drug that is not approved for human use and is banned by the World Anti-Doping Agency (WADA) due to its performance-enhancing potential.³

Mechanism and Bodybuilding Benefits 

SR-9009 is known for targeting the REV-ERB$\alpha$ and REV-ERB$\beta$ nuclear receptors.⁴ By activating these receptors, SR-9009 influences the body's circadian rhythm and metabolism at a cellular level, earning it the designation of an "exercise mimetic".⁵

• Metabolic Enhancement: SR-9009 promotes the use of stored fat as fuel by enhancing fatty acid oxidation and improving glucose metabolism.⁶ This dual action supports fat loss and contributes to a leaner body composition.⁷

• Endurance & Mitochondria: Research (primarily animal studies) indicates SR-9009 increases mitochondria counts and efficiency in skeletal muscle.⁸ This results in higher energy output, improved endurance, and reduced fatigue, mimicking the effects of exercise.

• Cardioprotection: Preclinical research suggests SR-9009 may exhibit cardioprotective properties, such as mitigating cardiac remodeling and promoting cardiac tissue repair.⁹

• Basal Metabolic Rate (BMR): It is thought to raise the BMR, enhancing overall energy expenditure even at rest.¹⁰

Usage and Dosage Guidelines (Illicit Use) 

• Dosage: Common illicit dosages typically range from 10 mg to 30 mg per day.¹¹ The provided concentration is $10 \text{ mg}/\text{capsule}$.

• Frequency: Due to its short half-life (estimated to be very short, requiring frequent dosing), some users divide the daily dose into 2–3 administrations throughout the day to maintain consistent receptor activation.¹²

• Cycle Length: Commonly run for 8 to 12 weeks.¹³

• Timing: Often taken shortly before exercise to maximize energy expenditure and endurance during the training session.

Side Effects and Risks 

SR-9009 has not been tested in humans, and its long-term safety profile is unknown.¹⁴

• Safety Status: SR-9009 is possibly unsafe when taken by mouth, as there is no reliable information regarding appropriate human dosing or safety.¹⁵

• Unknown Risks: Due to its role as a metabolic modulator and its influence on cellular processes, misuse carries risks that are not fully understood, including potential adverse effects on the heart.

 Frequently Asked Questions (FAQ)

1. What is the main mechanism of SR-9009 that promotes fat loss?

SR-9009 promotes fat loss by acting as a REV-ERB agonist, which enhances fatty acid oxidation and increases energy expenditure.¹⁶ This activation essentially helps the body use stored fat as fuel more efficiently.¹⁷

2. Why is SR-9009 referred to as an "exercise mimetic"?

It is referred to as an exercise mimetic because it influences physiological systems in a way that replicates the effects of physical exercise at a cellular level, such as stimulating mitochondrial biogenesis (the creation of new energy-producing organelles) and improving endurance.¹⁸

3. Has SR-9009 been proven safe for use by athletes?

No. SR-9009 has not been adequately tested in humans, its long-term effects are unknown, and it is banned by the World Anti-Doping Agency (WADA) due to safety and performance-enhancing concerns.¹⁹

4. Why might users of oral SR-9009 choose to divide their dose throughout the day?

The compound has a very short half-life.²⁰ Users often divide the daily dose into 2–3 administrations to try and maintain more consistent blood levels and continuous activation of the REV-ERB receptors throughout the day.²¹

SR9009 (Stenabolic): The Metabolic and Endurance Enhancer

Active Substance: SR9009 (Stenabolic)
Manufacturer: Deus Medical
Pack: 50 Tablets in Container (10 mg/capsule)
Form: Oral (Capsule/Tablet)

What Is SR9009 (Stenabolic)?

SR9009, commonly known as Stenabolic, is a potent research drug that is often mistakenly classified as a SARM (Selective Androgen Receptor Modulator). It is, in fact, an agonist of the REV-ERBα/REV-ERBβ nuclear receptors.  

Originally developed by Professor Thomas Burris to study the body's circadian rhythm, SR9009 influences the body's biological clock and metabolism, leading to effects that mimic the benefits of exercise. For this reason, it is classified as a Hormone and Metabolic Modulator by the World Anti-Doping Agency (WADA).  

Core Functions and Mechanism

SR9009 works by activating the REV-ERB receptors, which play a pivotal role in regulating cellular energy.  

• Mitochondrial Biogenesis: SR9009 increases the number and efficiency of mitochondria (the cell's powerhouses) in skeletal muscle. This results in higher energy output and reduced fatigue.  

• Enhanced Energy Expenditure: By activating REV-ERBα, it alters the circadian pattern of metabolic genes in the liver and skeletal muscle, increasing overall energy expenditure and raising the Basal Metabolic Rate (BMR), even at rest.  

• Fatty Acid Oxidation: It enhances the metabolism of both fatty acids and glucose, promoting a switch to fat burning and accelerating fat loss.  

• Endurance Boost: Studies in animal models showed SR9009 significantly increased exercise capacity, leading to its illicit use by athletes for its potent ergogenic effects.  

 Usage and Dosage Protocols

Due to its short half-life, SR9009 requires strict, multiple-daily dosing to maintain stable levels, despite its oral form.  

• Recommended Dosage: The generally recommended dosage for misuse ranges between 10 mg to 30 mg per day. Beginners are advised to start at 10 mg per day.  

• Administration Frequency: Due to a relatively short half-life, SR9009 requires multiple daily doses to maintain stable plasma levels. A common protocol is to divide the total daily intake into two to three equal doses, taken approximately every 4 to 6 hours.  

• Cycling Protocol: To prevent the development of tolerance, cycles typically range from 8 to 12 weeks, followed by a minimum 4-week break.  

 Side Effects and Warnings

SR9009 is an investigational drug, and its long-term safety profile in humans is unknown.

• Circadian Rhythm Interference: Because SR9009 directly influences the body's clock, one of the most common user-reported side effects is disrupted sleep, increased wakefulness, and insomnia.  

• Anecdotal Effects: Other reported side effects include nausea and headache.  

• WADA Prohibition: SR9009 is explicitly placed on the World Anti-Doping Agency (WADA) Prohibited List under the category of Hormone and Metabolic Modulators due to its potent ergogenic effects on endurance.  

 Frequently Asked Questions (FAQs)

1. Why must SR9009 be taken multiple times per day despite being a capsule?

SR9009 has a very short half-life (approximately 4 hours). Although it is an oral capsule, it is cleared from the body quickly. To maintain stable activation of the REV-ERB receptors and sustain the metabolic and endurance-boosting effects throughout the day, the total dose must be split into 2-3 administrations.

2. Is SR9009 a SARM or a Metabolic Modulator?

SR9009 is a Metabolic Modulator, specifically a REV-ERBα agonist. It is often falsely advertised as a SARM on the black market, but it does not bind to the androgen receptor. It modulates metabolism, endurance, and fat burning primarily through its effect on mitochondrial function and the circadian clock.  

3. Does SR9009 suppress natural testosterone production?

No. Since SR9009 does not bind to the androgen receptor (AR), it does not interfere with the HPTA (Hypothalamic-Pituitary-Testicular Axis). Therefore, SR9009 cycles do not require standard Post Cycle Therapy (PCT) protocols using SERMs (like Nolvadex or Clomid).

4. What is the primary safety risk associated with SR9009?

The primary user-reported risks are related to disrupted sleep and circadian rhythm interference due to its REV-ERBα mechanism. As a research chemical not FDA-approved, the long-term systemic risks in humans are completely unknown, and it should be approached with extreme caution.